Molecular effects of exercise in patients with inflammatory rheumatic disease (Q37288406)

19 August 2017

1 reference

title

Molecular effects of exercise in patients with inflammatory rheumatic disease (English)

1 reference

19 August 2017

0 references

1

Ingrid E Lundberg

1 reference

19 August 2017

Gustavo A Nader

2

1 reference

19 August 2017

7 October 2008

1 reference

Nature Clinical Practice Rheumatology

19 August 2017

1 reference

19 August 2017

4

1 reference

19 August 2017

597-604

1 reference

19 August 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/ncprheum0929

19 August 2017

0 references

cites work

Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

Cyclic tensile strain acts as an antagonist of IL-1 beta actions in chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

Effect of Short-Term Physical Training on Patients with Rheumatoid Arthritis I

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Evidence for the benefit of aerobic and strengthening exercise in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Positive effects of moderate exercise on glycosaminoglycan content in knee cartilage: a four-month, randomized, controlled trial in patients at risk of osteoarthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Improvement of physical fitness and muscle strength in polymyositis/dermatomyositis patients by a training programme

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Benefit of 6 months long-term physical training in polymyositis/dermatomyositis patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Safety of a home exercise programme in patients with polymyositis and dermatomyositis: a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

The safety of a resistive home exercise program in patients with recent onset active polymyositis or dermatomyositis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

The effect of physical exercise following acute disease exacerbation in patients with dermato/polymyositis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Safety and efficacy of submaximal eccentric strength training for a subject with polymyositis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Effects of concurrent strength and endurance training in women with early or longstanding rheumatoid arthritis: Comparison with healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

A randomized two-year study of the effects of dynamic strength training on muscle strength, disease activity, functional capacity, and bone mineral density in early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Effect of intensive exercise on patients with active rheumatoid arthritis: a randomised clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Protein metabolism in rheumatoid arthritis and aging. Effects of muscle strength training and tumor necrosis factor α

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Changes in inflammatory biomarkers following one-year of moderate resistance training in overweight women.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

An exercise intervention without weight loss decreases circulating interleukin-6 in lean and obese men with and without type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Markers of inflammation are inversely associated with VO2 max in asymptomatic men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Physical inactivity in patients with rheumatoid arthritis: data from twenty-one countries in a cross-sectional, international study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Rheumatoid myositis. Clinical and histologic features and possible pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Changes in muscle fibre size and physical performance in patients with rheumatoid arthritis after 7 months physical training

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Respiratory and limb muscle weakness induced by tumor necrosis factor-alpha: involvement of muscle myofilaments

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Activation of the endoplasmic reticulum stress response in autoimmune myositis: Potential role in muscle fiber damage and dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Cachexia in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Molecular determinants of skeletal muscle mass: getting the "AKT" together

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca2+ -activated, and ubiquitin-proteasome proteolytic pathways.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Role of calpain in skeletal-muscle protein degradation

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Signaling pathways weigh in on decisions to make or break skeletal muscle

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Tumor necrosis factor-regulated biphasic activation of NF-kappa B is required for cytokine-induced loss of skeletal muscle gene products

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Tumour necrosis factor blockade did not prevent the increase of muscular muscle RING finger-1 and muscle atrophy F-box in arthritic rats.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Adaptive response of mammalian skeletal muscle to exercise with high loads

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Immunological changes in human skeletal muscle and blood after eccentric exercise and multiple biopsies

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Effect of physical training on the proportion of slow-twitch type I muscle fibers, a novel nonimmune-mediated mechanism for muscle impairment in polymyositis or dermatomyositis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Effects of exercise training on quadriceps muscle gene expression in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: Six-month, double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Dynamic biophysical strain modulates proinflammatory gene induction in meniscal fibrochondrocytes

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Biomechanical signals exert sustained attenuation of proinflammatory gene induction in articular chondrocytes

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Biomechanical signals inhibit IKK activity to attenuate NF-kappaB transcription activity in inflamed chondrocytes

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0929

7 January 2021

Identifiers

DOI

10.1038/NCPRHEUM0929

1 reference

PubMed ID

18839010

Dimensions Publication ID

19 August 2017

0 references

1 reference

PubMed ID

18839010